cisapride has been researched along with Canine Diseases in 6 studies
Cisapride: A substituted benzamide used for its prokinetic properties. It is used in the management of gastroesophageal reflux disease, functional dyspepsia, and other disorders associated with impaired gastrointestinal motility. (Martindale The Extra Pharmacopoeia, 31st ed)
cisapride : The amide resulting from formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with cis-1-[3-(4-fluorophenoxy)propyl]-3-methoxypiperidin-4-amine. It has been used (as its monohydrate or as its tartrate) for the treatment of gastro-oesophageal reflux disease and for non-ulcer dyspepsia, but its propensity to cause cardiac arrhythmias resulted in its complete withdrawal from many countries, including the U.K., and restrictions on its use elsewhere.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Cisapride is an oral prokinetic agent used to facilitate or restore motility in the gastrointestinal tract." | 2.39 | Cisapride toxicosis in dogs. ( Volmer, PA, 1996) |
| "The cisapride protocol was largely well tolerated." | 1.51 | Effects of preoperative cisapride on postoperative aspiration pneumonia in dogs with laryngeal paralysis. ( Ogden, J; Ovbey, D; Saile, K, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ogden, J | 1 |
| Ovbey, D | 1 |
| Saile, K | 1 |
| Schmitz, S | 1 |
| Fink, T | 1 |
| Failing, K | 1 |
| Borsch, C | 1 |
| Kunz, C | 1 |
| Clemence, R | 1 |
| Savary-Bataille, K | 1 |
| Neiger, R | 1 |
| Washabau, RJ | 2 |
| Poncet, CM | 1 |
| Dupre, GP | 1 |
| Freiche, VG | 1 |
| Bouvy, BM | 1 |
| Volmer, PA | 1 |
| Hall, JA | 1 |
3 reviews available for cisapride and Canine Diseases
| Article | Year |
|---|---|
Gastrointestinal motility disorders and gastrointestinal prokinetic therapy.
Topics: Animals; Benzofurans; Cisapride; Dog Diseases; Dogs; Gastrointestinal Agents; Gastrointestinal Motil | 2003 |
Cisapride toxicosis in dogs.
Topics: Administration, Oral; Animals; Anti-Ulcer Agents; Cisapride; Dog Diseases; Dogs; Drug Interactions; | 1996 |
Diagnosis and treatment of gastric motility disorders.
Topics: Animals; Cat Diseases; Cats; Cisapride; Dog Diseases; Dogs; Erythromycin; Gastric Emptying; Gastroin | 1999 |
1 trial available for cisapride and Canine Diseases
| Article | Year |
|---|---|
Effects of the neurokinin-1 antagonist maropitant on canine gastric emptying assessed by radioscintigraphy and breath test.
Topics: Animals; Breath Tests; Cisapride; Cross-Over Studies; Dog Diseases; Dogs; Gastric Emptying; Gastroin | 2016 |
2 other studies available for cisapride and Canine Diseases
| Article | Year |
|---|---|
Effects of preoperative cisapride on postoperative aspiration pneumonia in dogs with laryngeal paralysis.
Topics: Animals; Cisapride; Dog Diseases; Dogs; Pneumonia, Aspiration; Postoperative Complications; Retrospe | 2019 |
Long-term results of upper respiratory syndrome surgery and gastrointestinal tract medical treatment in 51 brachycephalic dogs.
Topics: Airway Obstruction; Analysis of Variance; Animals; Anti-Ulcer Agents; Cisapride; Dog Diseases; Dogs; | 2006 |